Amylx Pharmaceuticals Inc vs Oklo Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Oklo Inc trades at $47.25 (market cap $8.74B). The key difference: Oklo Inc is far larger — about 3.3× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | OKLO | |
|---|---|---|
Market Cap | $2.64B | $8.74B |
Sector | Health | Technology |
52-Week High | $24.19 | $174.14 |
52-Week Low | $7.82 | $36.84 |
Enterprise Value | $2.39B | $6.28B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →